Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches. (2021). Biomolecules and Biomedicine, 21(3), 270-283. https://doi.org/10.17305/bjbms.2020.5016